Neptune is interesting because they have been very tight-lipped. They haven’t announced the dollar value of their extraction deals whereas MediPharm has. They also have not provided any forward guidance. So it is a case where the dollar volume is already very low and the true value needs to be pieced together through careful research and analysis.
Once revenues become realized (remember, shipments for both of those deals — Tilray and TGOD — were stated to begin in September) and/or some forward guidance is given, that will make the value here easily digestible and bring in new investors. Until then, we will blow around like a leaf in the wind depending on what the sector does.
I myself have been using this as an opportunity to average down and with the long-term vision in focus I see this recent slide as a positive short-term opportunity rather than lamenting it as unrealized losses.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM